4-ANTIBODY AG
4-Antibody AG develops human antibody drug-discovery platform for generating antibody therapeutics focused on immuno-oncology. Its technology platform Retrocyte Display is designed to generate therapeutic antibody drug candidates incorporating human antibody libraries expressed in mammalian B-lineage lymphocytes. The company also develops preclinical checkpoint antibody programs targeting GITR, OX40, CTLA-4, PD-1, TIM-3, and LAG-3. 4-Antibody AG was founded in 2002 and is based in Basel, Switzerland.
4-ANTIBODY AG
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2002-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.4-antibody.com
Total Employee:
251+
Status:
Active
Contact:
+41616332260
Total Funding:
25.75 M CHF
Technology used in webpage:
SPF IPv6 Microsoft Azure DNS PHP Microsoft DNS Made Easy DNS DNS Made Easy Tiggee
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Current Employees Featured
Investors List
Grazia Equity
Grazia Equity investment in Series A - 4-Antibody AG
Life Sciences Partners
Life Sciences Partners investment in Series A - 4-Antibody AG
Advent Venture Partners
Advent Venture Partners investment in Series A - 4-Antibody AG
Life Sciences Partners
Life Sciences Partners investment in Seed Round - 4-Antibody AG
Grazia Equity
Grazia Equity investment in Seed Round - 4-Antibody AG
BioMedPartners
BioMedPartners investment in Seed Round - 4-Antibody AG
Mulligan BioCapital
Mulligan BioCapital investment in Seed Round - 4-Antibody AG
Official Site Inspections
http://www.4-antibody.com
- Host name: redirection.dnsmadeeasy.com
- IP address: 96.45.82.102
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
